Ignite Creation Date:
2025-12-24 @ 6:54 PM
Ignite Modification Date:
2026-04-19 @ 7:23 AM
Study NCT ID:
NCT05981157
Status:
RECRUITING
Last Update Posted:
2023-08-08
First Post:
2023-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anrotinib and Tirelizumab in First-line Treatment of RM-NPC
Sponsor:
Organization: